Archive

To launch new drugs for diabetes and coronary heart disease

The acquisition positions CGI to immediately participate in the high growth Indian molecular diagnostics and oncology services…

Key topics discussed included audio visual recording of informed consent and reimbursement

Focus on building Brand India Pharma, through regulatory reform and raising standards to global norms

Nine therapies have outgrown the IPM growth and five therapies have double digit growths

As we go to press, the Pfizer-AstraZeneca deal is called off for now but that story is far from over

60 percent of respondents think that medical devices are the same as pharmaceuticals

{source}<div data-configid="5690019/8139674" style="width: 600px; height: 396px;" class="issuuembed"></div><script…

Aims to increase awareness towards the environment

To establish a scientific Centre of Excellence for natural products that will initially focus on the production of agarwood…

The manufacturing facility supplements the research and development capabilities and will facilitate production of clinical grade…

Extends five-year extension of their drug discovery and development collaboration

The product is designed for mixed multi-drug infections for paediatric, geriatric and adult immuno-compromised patients

The ANDAs has been approved out of Unit VII (SEZ) formulation facility in Hyderabad

To provide easy access to valuable FDA public data

During the year the sales volume grew by 37 per cent and profit has grown by 47 per cent Y-o-Y

Celecoxib is a non-Steroidal Anti-Inflammatory Drug

The batch of 30 students underwent an intensive 16-week advanced learning programme and hands-on professional training

Royal DSM recently inaugurated its 14th Fortitech premixes plant in Vadodara, Gujarat, a first-of-its-kind facility in India. It…

From humble beginnings in technologies for the pharma industry coupled with an uncompromising stance on quality to deliver the…